Effect of 10-day Overnight Hypoxia Treatment on Whole Body Insulin Sensitivity (SLEEP HIGH Study)
NCT01872533 · Status: COMPLETED · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 9
Last updated 2015-12-02
Summary
The purpose of this study is to look at how a reduction in oxygen levels (hypoxia) influences insulin sensitivity and carbohydrate metabolism. It is expected that 10 nights of exposure to moderate hypoxia (\~ 15% O2, similar to conditions at an altitude of \~7500 feet) will improve glucose metabolism.
Conditions
Interventions
- OTHER
-
Hypoxia Exposure
Participants spent 10 consecutive nights (approximately 100 hours of exposure) in a hypoxic tent at \~ 15% O2 (ca. 2400 m elevation).
Sponsors & Collaborators
-
Pennington Biomedical Research Center
lead OTHER
Study Design
- Allocation
- NA
- Purpose
- PREVENTION
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 20 Years
- Max Age
- 45 Years
- Sex
- MALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2011-07-31
- Primary Completion
- 2012-09-30
- Completion
- 2013-05-31
Countries
- United States
Study Locations
More Related Trials
-
Sleep Apnea in Type 1 Diabetes
NCT01935765 ·Status: COMPLETED ·Phase: NA
-
Insulin Variance Throughout the Day
NCT01546545 ·Status: COMPLETED
-
Incretin Effect in Lean and Obese Subjects
NCT00803296 ·Status: COMPLETED
-
Beta-Cell Function After Near-Normalisation of Blood Glucose
NCT00612950 ·Status: COMPLETED ·Phase: NA
-
Exercise and GLP-1 RA on Insulin Secretion
NCT04383197 ·Status: UNKNOWN ·Phase: NA
-
The Relationship Between Sleep and Glucose Tolerance in Prediabetes: the Role of GLP-1 in Short Sleepers
NCT02229487 ·Status: COMPLETED ·Phase: NA
-
A Study to Determine Iatrogenic Hyperinsulinemia's Contribution to Insulin Resistance and Endothelial Dysfunction in Type 1 Diabetes
NCT04118374 ·Status: COMPLETED ·Phase: NA
-
Glucotoxicity and Acute Exercise
NCT01771614 ·Status: WITHDRAWN ·Phase: NA
-
Importance in Type 1 Diabetes Patients of an Optimized Control of Post-Prandial Glycaemia on Oxidant Stress Prevention
NCT00934336 ·Status: COMPLETED ·Phase: NA
-
Effect of a Glucagon Like Peptide 1 (GLP1) Booster in Healthy Humans
NCT06333496 ·Status: COMPLETED ·Phase: NA
-
Effect of Physiologic Insulin Administration on Insulin Sensitivity and Cognition
NCT07265323 ·Status: RECRUITING ·Phase: NA
-
Insulin Deprivation on Brain Structure and Function in Humans With Type 1 Diabetes
NCT03392441 ·Status: COMPLETED ·Phase: NA
-
Acute Effects of SGLT2 Inhibition on Renal Oxygenation and Autonomic Function in Type 1 Diabetes
NCT04193566 ·Status: COMPLETED ·Phase: PHASE4
-
The Importance of Meal Composition on Preventing Exercise-induced Hypoglycemia in People With Type 1 Diabetes.
NCT04472962 ·Status: COMPLETED ·Phase: NA
-
A Pilot Study of the Effects on Sleep Disordered Breathing (SDB) When Using the Drug Liraglutide for 4 Weeks
NCT01832532 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Impact of Dopamine Infusion on Insulin Secretion in Healthy Subjects
NCT02053935 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluation of the Impact of Intensive Short-Term Drug Therapy in Patients With Type 2 Diabetes Mellitus
NCT04027023 ·Status: UNKNOWN ·Phase: PHASE4
-
Influence of Central Nervous Insulin Action on Insulin Sensitivity of Peripheral Organs in Lean Versus Overweight Humans
NCT02468999 ·Status: COMPLETED ·Phase: NA
-
Study of the Use of [18F]-DOPA in Hyperinsulinemic Hypoglycemia
NCT02533219 ·Status: NO_LONGER_AVAILABLE
-
"Effect of Central Insulin Administration on Whole-body Insulin Sensitivity in Women"
NCT03929419 ·Status: COMPLETED ·Phase: NA
-
GLP-1 and Hypoglycemia
NCT01858896 ·Status: ACTIVE_NOT_RECRUITING ·Phase: EARLY_PHASE1
-
Interventions Against Insulin Resistance in Pulmonary Arterial Hypertension
NCT03617458 ·Status: COMPLETED ·Phase: PHASE2
-
Insulinotropic Effect of GIP and GLP-1 Before and After Reduced Glucose Tolerance
NCT01173978 ·Status: COMPLETED ·Phase: NA
-
The Acute Effects of Low-dose TNF-α on Glucose Metabolism and β-cell Function in Humans
NCT01953393 ·Status: COMPLETED ·Phase: NA
-
Improving Insulin Sensitivity by Non-invasive Brain Stimulation in Persons With Insulin Resistance
NCT04052399 ·Status: UNKNOWN ·Phase: NA